Cytomedix Inc
(OTCBB: CMXI)
| Exchange: | OTCBB |
| Stock: | Cytomedix, Inc. |
| Industry: | Biotechnology |
| Employees: | 50 |
| Cytomedix, Inc. is a United States-based company that develops biologically active regenerative therapies for wound and tissue repair. The Company offers PRP systems for the surgical suite and chronic wound repair. Its AutoloGel System harnesses the patient's natural healing processes with the delivery of a platelet rich plasma gel containing growth factors, cytokines and chemokines for cell growth and formation of new tissue. The Company serves perfusionists, blood management professionals, surgeons and wound care clinicians. |
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
